Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cue Health Inc (HLTH)

Cue Health Inc (HLTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,227
  • Shares Outstanding, K 159,092
  • Annual Sales, $ 70,940 K
  • Annual Income, $ -373,460 K
  • 60-Month Beta 1.23
  • Price/Sales 0.34
  • Price/Cash Flow N/A
  • Price/Book 0.09
Trade HLTH with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.73
  • Most Recent Earnings $-0.32 on 03/13/24
  • Latest Earnings Date 05/08/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 351.15% ( +351.15%)
  • Historical Volatility 91.78%
  • IV Percentile 21%
  • IV Rank 18.60%
  • IV High 1,352.56% on 08/14/23
  • IV Low 122.28% on 01/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 126
  • Open Int (30-Day) 129

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.40
  • Number of Estimates 1
  • High Estimate -0.40
  • Low Estimate -0.40
  • Prior Year -0.48
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1320 +8.11%
on 04/22/24
0.1984 -28.07%
on 03/26/24
-0.0391 (-21.51%)
since 03/25/24
3-Month
0.1320 +8.11%
on 04/22/24
0.3500 -59.23%
on 02/29/24
-0.0795 (-35.78%)
since 01/25/24
52-Week
0.1320 +8.11%
on 04/22/24
0.9884 -85.56%
on 04/26/23
-0.7475 (-83.97%)
since 04/25/23

Most Recent Stories

More News
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced an expansion of its Cue Integrated Care Platform to include a new pharmacy offering with over-the-counter and prescription...

HLTH : 0.1428 (-2.19%)
Cue Health to Announce First Quarter 2023 Financial Results

Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2023 financial results on Wednesday, May 10, 2023. In conjunction with...

HLTH : 0.1428 (-2.19%)
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cue Health Inc. (“Cue Health” or “the Company”) (NASDAQ:...

HLTH : 0.1428 (-2.19%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cue Health Inc. (“Cue Health” or “the Company”) (NASDAQ:...

HLTH : 0.1428 (-2.19%)
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for its...

HLTH : 0.1428 (-2.19%)
Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results

Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2022.

HLTH : 0.1428 (-2.19%)
Cue Health’s New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced the nationwide launch of a new suite of consumer-friendly, at-home diagnostic test kits. These easy-to-use kits provide...

HLTH : 0.1428 (-2.19%)
Cue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment Journey

Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology leader in at-home and point-of-care diagnostic innovations, today announced a new collaboration with Pfizer Inc. in the U.S. to raise awareness...

HLTH : 0.1428 (-2.19%)
Cue Health to Announce Fourth Quarter and Full-Year 2022 Financial Results

Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full-year 2022 financial results on Wednesday, March 15, 2023. In...

HLTH : 0.1428 (-2.19%)
Cue Health to Participate at Upcoming Investor Conferences

Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology company known for diagnostic enabled care, announced today that its management team will participate at the following investor conferences:...

HLTH : 0.1428 (-2.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, at work or at the point-of-care, all in a device. Cue Health Inc. is headquartered in San Diego.

See More

Key Turning Points

3rd Resistance Point 0.1680
2nd Resistance Point 0.1619
1st Resistance Point 0.1540
Last Price 0.1428
1st Support Level 0.1400
2nd Support Level 0.1339
3rd Support Level 0.1260

See More

52-Week High 0.9884
Fibonacci 61.8% 0.6613
Fibonacci 50% 0.5602
Fibonacci 38.2% 0.4591
Last Price 0.1428
52-Week Low 0.1320

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar